DGX logo

DGX EBITDA

annual EBITDA:

$1.87B+$137.00M(+7.91%)
December 31, 2024

Summary

  • As of today (June 3, 2025), DGX annual EBITDA is $1.87 billion, with the most recent change of +$137.00 million (+7.91%) on December 31, 2024.
  • During the last 3 years, DGX annual EBITDA has fallen by -$1.29 billion (-40.84%).
  • DGX annual EBITDA is now -40.84% below its all-time high of $3.16 billion, reached on December 31, 2021.

Performance

DGX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXincome statement metrics

quarterly EBITDA:

$488.00M-$18.00M(-3.56%)
March 31, 2025

Summary

  • As of today (June 3, 2025), DGX quarterly EBITDA is $488.00 million, with the most recent change of -$18.00 million (-3.56%) on March 31, 2025.
  • Over the past year, DGX quarterly EBITDA has increased by +$57.00 million (+13.23%).
  • DGX quarterly EBITDA is now -48.90% below its all-time high of $955.00 million, reached on June 30, 2021.

Performance

DGX quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXincome statement metrics

TTM EBITDA:

$1.95B+$57.00M(+3.01%)
March 31, 2025

Summary

  • As of today (June 3, 2025), DGX TTM EBITDA is $1.95 billion, with the most recent change of +$57.00 million (+3.01%) on March 31, 2025.
  • Over the past year, DGX TTM EBITDA has increased by +$209.00 million (+12.00%).
  • DGX TTM EBITDA is now -44.26% below its all-time high of $3.50 billion, reached on June 30, 2021.

Performance

DGX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

DGX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.9%+13.2%+12.0%
3 y3 years-40.8%-18.0%-34.7%
5 y5 years+17.9%+99.2%+31.1%

DGX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-40.8%+7.9%-18.0%+87.0%-34.7%+21.9%
5 y5-year-40.8%+17.9%-48.9%+99.2%-44.3%+31.6%
alltimeall time-40.8%+472.2%-48.9%+1661.7%-44.3%+4980.7%

DGX EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$488.00M(-3.6%)
$1.95B(+3.0%)
Dec 2024
$1.87B(+7.9%)
$506.00M(+5.6%)
$1.89B(+6.4%)
Sep 2024
-
$479.00M(+0.2%)
$1.78B(+1.6%)
Jun 2024
-
$478.00M(+10.9%)
$1.75B(+0.6%)
Mar 2024
-
$431.00M(+9.9%)
$1.74B(+0.6%)
Dec 2023
$1.73B(-4.8%)
$392.00M(-13.1%)
$1.73B(+8.2%)
Sep 2023
-
$451.00M(-3.6%)
$1.60B(-2.7%)
Jun 2023
-
$468.00M(+11.2%)
$1.65B(0.0%)
Mar 2023
-
$421.00M(+61.3%)
$1.65B(-9.6%)
Dec 2022
$1.82B(-42.4%)
$261.00M(-47.4%)
$1.82B(-17.5%)
Sep 2022
-
$496.00M(+6.0%)
$2.21B(-11.9%)
Jun 2022
-
$468.00M(-21.3%)
$2.50B(-16.3%)
Mar 2022
-
$595.00M(-7.9%)
$2.99B(-5.4%)
Dec 2021
$3.16B(+31.0%)
$646.00M(-18.5%)
$3.16B(-7.3%)
Sep 2021
-
$793.00M(-17.0%)
$3.41B(-2.6%)
Jun 2021
-
$955.00M(+24.8%)
$3.50B(+19.4%)
Mar 2021
-
$765.00M(-14.6%)
$2.93B(+21.6%)
Dec 2020
$2.41B(+52.1%)
$896.00M(+1.4%)
$2.41B(+22.4%)
Sep 2020
-
$884.00M(+129.0%)
$1.97B(+32.9%)
Jun 2020
-
$386.00M(+57.6%)
$1.48B(-0.4%)
Mar 2020
-
$245.00M(-46.0%)
$1.49B(-6.1%)
Dec 2019
$1.58B(+12.9%)
$454.00M(+14.4%)
$1.58B(+11.5%)
Sep 2019
-
$397.00M(+1.3%)
$1.42B(+0.9%)
Jun 2019
-
$392.00M(+15.0%)
$1.41B(+0.6%)
Mar 2019
-
$341.00M(+17.2%)
$1.40B(-0.2%)
Dec 2018
$1.40B(-3.4%)
$291.00M(-24.4%)
$1.40B(-3.8%)
Sep 2018
-
$385.00M(+0.3%)
$1.46B(+1.3%)
Jun 2018
-
$384.00M(+11.6%)
$1.44B(-0.8%)
Mar 2018
-
$344.00M(-0.6%)
$1.45B(-0.1%)
Dec 2017
$1.45B(-1.8%)
$346.00M(-5.5%)
$1.45B(+0.3%)
Sep 2017
-
$366.00M(-7.6%)
$1.45B(-1.6%)
Jun 2017
-
$396.00M(+14.8%)
$1.47B(-5.3%)
Mar 2017
-
$345.00M(+1.2%)
$1.55B(+5.1%)
Dec 2016
$1.48B(-5.3%)
$341.00M(-12.3%)
$1.48B(+1.7%)
Sep 2016
-
$389.00M(-18.8%)
$1.45B(-17.8%)
Jun 2016
-
$479.00M(+77.4%)
$1.77B(+10.4%)
Mar 2016
-
$270.00M(-14.6%)
$1.60B(+2.7%)
Dec 2015
$1.56B(+19.7%)
$316.00M(-55.1%)
$1.56B(-1.4%)
Sep 2015
-
$704.00M(+125.6%)
$1.58B(+30.4%)
Jun 2015
-
$312.00M(+36.8%)
$1.21B(-3.2%)
Mar 2015
-
$228.00M(-32.5%)
$1.25B(-4.8%)
Dec 2014
$1.30B(-26.3%)
$338.00M(+0.9%)
$1.32B(+0.9%)
Sep 2014
-
$335.00M(-4.8%)
$1.30B(-24.9%)
Jun 2014
-
$352.00M(+21.0%)
$1.74B(-0.9%)
Mar 2014
-
$291.00M(-10.7%)
$1.75B(-1.0%)
Dec 2013
$1.77B(+16.2%)
$326.00M(-57.5%)
$1.77B(-1.0%)
Sep 2013
-
$767.00M(+108.4%)
$1.79B(+27.3%)
Jun 2013
-
$368.00M(+19.5%)
$1.40B(-3.0%)
Mar 2013
-
$308.00M(-10.6%)
$1.45B(-4.9%)
Dec 2012
$1.52B(+17.0%)
$344.34M(-10.3%)
$1.52B(-3.5%)
Sep 2012
-
$383.70M(-6.9%)
$1.58B(-1.1%)
Jun 2012
-
$411.94M(+7.6%)
$1.59B(+0.9%)
Mar 2012
-
$383.02M(-4.0%)
$1.58B(+21.4%)
Dec 2011
$1.30B(-17.3%)
$399.00M(-0.4%)
$1.30B(+3.4%)
Sep 2011
-
$400.68M(+0.9%)
$1.26B(-0.9%)
Jun 2011
-
$397.10M(+279.7%)
$1.27B(-2.5%)
Mar 2011
-
$104.58M(-70.7%)
$1.30B(-17.3%)
DateAnnualQuarterlyTTM
Dec 2010
$1.57B(-3.5%)
$356.50M(-13.4%)
$1.57B(-2.1%)
Sep 2010
-
$411.63M(-4.1%)
$1.61B(-0.8%)
Jun 2010
-
$429.41M(+14.1%)
$1.62B(+0.3%)
Mar 2010
-
$376.45M(-3.6%)
$1.62B(-1.0%)
Dec 2009
$1.63B(+11.0%)
$390.41M(-8.1%)
$1.63B(+1.6%)
Sep 2009
-
$424.61M(+0.2%)
$1.61B(+2.7%)
Jun 2009
-
$423.96M(+8.1%)
$1.56B(+2.5%)
Mar 2009
-
$392.22M(+7.5%)
$1.53B(+3.2%)
Dec 2008
$1.47B(+10.5%)
$364.87M(-4.8%)
$1.48B(-1.1%)
Sep 2008
-
$383.08M(-0.5%)
$1.49B(+0.9%)
Jun 2008
-
$385.13M(+11.5%)
$1.48B(+4.1%)
Mar 2008
-
$345.52M(-9.2%)
$1.42B(+7.1%)
Dec 2007
$1.33B(+0.3%)
$380.69M(+2.9%)
$1.33B(+4.1%)
Sep 2007
-
$370.02M(+13.0%)
$1.28B(+2.2%)
Jun 2007
-
$327.31M(+30.3%)
$1.25B(-1.5%)
Mar 2007
-
$251.21M(-23.5%)
$1.27B(-4.3%)
Dec 2006
$1.33B(+12.0%)
$328.49M(-4.0%)
$1.33B(+1.6%)
Sep 2006
-
$342.25M(-1.3%)
$1.30B(+3.9%)
Jun 2006
-
$346.89M(+12.7%)
$1.26B(+3.5%)
Mar 2006
-
$307.78M(+0.1%)
$1.21B(+3.0%)
Dec 2005
$1.18B(+12.8%)
$307.60M(+4.7%)
$1.18B(+4.9%)
Sep 2005
-
$293.81M(-3.4%)
$1.12B(+1.8%)
Jun 2005
-
$304.20M(+11.7%)
$1.10B(+2.9%)
Mar 2005
-
$272.44M(+7.9%)
$1.07B(+2.1%)
Dec 2004
$1.05B(+10.4%)
$252.52M(-7.9%)
$1.05B(+1.5%)
Sep 2004
-
$274.24M(+0.5%)
$1.03B(+1.8%)
Jun 2004
-
$272.87M(+9.2%)
$1.02B(+1.6%)
Mar 2004
-
$249.95M(+5.3%)
$1.00B(+5.2%)
Dec 2003
$950.36M(+31.3%)
$237.41M(-7.3%)
$950.59M(+6.4%)
Sep 2003
-
$256.05M(-0.4%)
$893.16M(+7.7%)
Jun 2003
-
$256.95M(+28.4%)
$829.02M(+8.3%)
Mar 2003
-
$200.18M(+11.2%)
$765.24M(+5.7%)
Dec 2002
$723.84M(+29.5%)
$179.98M(-6.2%)
$723.84M(+5.4%)
Sep 2002
-
$191.91M(-0.7%)
$686.67M(+7.8%)
Jun 2002
-
$193.17M(+21.7%)
$636.99M(+7.2%)
Mar 2002
-
$158.78M(+11.2%)
$594.04M(+6.2%)
Dec 2001
$559.12M(+23.7%)
$142.81M(+0.4%)
$559.12M(+9.9%)
Sep 2001
-
$142.23M(-5.3%)
$508.71M(+3.6%)
Jun 2001
-
$150.22M(+21.3%)
$491.27M(+3.2%)
Mar 2001
-
$123.85M(+34.0%)
$476.11M(+5.3%)
Dec 2000
$452.11M(+86.2%)
$92.41M(-25.9%)
$452.11M(+1.3%)
Sep 2000
-
$124.79M(-7.6%)
$446.20M(+14.3%)
Jun 2000
-
$135.06M(+35.3%)
$390.42M(+28.6%)
Mar 2000
-
$99.85M(+15.4%)
$303.50M(+25.0%)
Dec 1999
$242.80M(+48.9%)
$86.50M(+25.4%)
$242.87M(+24.6%)
Sep 1999
-
$69.00M(+43.3%)
$194.87M(+18.4%)
Jun 1999
-
$48.15M(+22.8%)
$164.57M(+2.2%)
Mar 1999
-
$39.22M(+1.9%)
$161.02M(-1.3%)
Dec 1998
$163.10M(+7.9%)
$38.50M(-0.5%)
$163.20M(+7.1%)
Sep 1998
-
$38.70M(-13.2%)
$152.40M(+0.7%)
Jun 1998
-
$44.60M(+7.7%)
$151.30M(-1.7%)
Mar 1998
-
$41.40M(+49.5%)
$153.90M(+2.0%)
Dec 1997
$151.10M(-130.1%)
$27.70M(-26.3%)
$150.90M(+22.5%)
Sep 1997
-
$37.60M(-20.3%)
$123.20M(+43.9%)
Jun 1997
-
$47.20M(+22.9%)
$85.60M(+122.9%)
Mar 1997
-
$38.40M
$38.40M
Dec 1996
-$502.19M
-
-

FAQ

  • What is Quest Diagnostics Incorporated annual EBITDA?
  • What is the all time high annual EBITDA for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated annual EBITDA year-on-year change?
  • What is Quest Diagnostics Incorporated quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated quarterly EBITDA year-on-year change?
  • What is Quest Diagnostics Incorporated TTM EBITDA?
  • What is the all time high TTM EBITDA for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated TTM EBITDA year-on-year change?

What is Quest Diagnostics Incorporated annual EBITDA?

The current annual EBITDA of DGX is $1.87B

What is the all time high annual EBITDA for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high annual EBITDA is $3.16B

What is Quest Diagnostics Incorporated annual EBITDA year-on-year change?

Over the past year, DGX annual EBITDA has changed by +$137.00M (+7.91%)

What is Quest Diagnostics Incorporated quarterly EBITDA?

The current quarterly EBITDA of DGX is $488.00M

What is the all time high quarterly EBITDA for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high quarterly EBITDA is $955.00M

What is Quest Diagnostics Incorporated quarterly EBITDA year-on-year change?

Over the past year, DGX quarterly EBITDA has changed by +$57.00M (+13.23%)

What is Quest Diagnostics Incorporated TTM EBITDA?

The current TTM EBITDA of DGX is $1.95B

What is the all time high TTM EBITDA for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high TTM EBITDA is $3.50B

What is Quest Diagnostics Incorporated TTM EBITDA year-on-year change?

Over the past year, DGX TTM EBITDA has changed by +$209.00M (+12.00%)
On this page